InspireMD (NSPR) EBIAT (2016 - 2025)
Historic EBIAT for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to -$12.7 million.
- InspireMD's EBIAT fell 6106.46% to -$12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.2 million, marking a year-over-year decrease of 6361.74%. This contributed to the annual value of -$32.0 million for FY2024, which is 6069.99% down from last year.
- Per InspireMD's latest filing, its EBIAT stood at -$12.7 million for Q3 2025, which was down 6106.46% from -$13.2 million recorded in Q2 2025.
- InspireMD's EBIAT's 5-year high stood at -$3.2 million during Q1 2021, with a 5-year trough of -$13.2 million in Q2 2025.
- In the last 5 years, InspireMD's EBIAT had a median value of -$5.1 million in 2023 and averaged -$6.4 million.
- As far as peak fluctuations go, InspireMD's EBIAT tumbled by 8231.08% in 2021, and later surged by 502.12% in 2023.
- Quarter analysis of 5 years shows InspireMD's EBIAT stood at -$4.1 million in 2021, then fell by 18.26% to -$4.8 million in 2022, then fell by 11.56% to -$5.4 million in 2023, then plummeted by 69.73% to -$9.2 million in 2024, then crashed by 38.52% to -$12.7 million in 2025.
- Its last three reported values are -$12.7 million in Q3 2025, -$13.2 million for Q2 2025, and -$11.2 million during Q1 2025.